A treatment with extracellular vesicles (EVs) in a homozygous KI mutant Dsg2 mouse decreased cardiac inflammation and arrhythmia episodes, with a global enhancement of cardiac function [24]. This evidence concerns the gene DSG2 and cardiac arrhythmia.